Features of Metabolism in Women with Preeclampsia Combined with Gestational Diabetes Mellitus
https://doi.org/10.31550/1727-2378-2023-22-1-62-67
Abstract
Objective of the Review: To summarize the proven prognostic and diagnostic criteria for gestational complications caused by a combination of gestational diabetes mellitus (GDM) and preeclampsia (PE).
Key points. There is an analytical review of the modern paradigm of GDM and PE, their complications, as well as perinatal and long-term outcomes for mother and child. The data on clinical, anamnestic and laboratory risk factors of PE in GDM are systematized. A close relationship between the mechanisms of PE and GDM development — angiogenic imbalance and metabolic disorders in the placenta is described.
Conclusion. GDM is recognized as an independent risk factor for the development of PE, and this risk is the greater the less GDM is compensated. Polycystic ovary syndrome and an increased body mass index as concomitant factors of metabolic disorders also increase the risk of developing PE. The supposed pathogenetic commonality of GDM and PE is the presence of oxidative stress and metaflammation, which increase insulin resistance and cause endothelial dysfunction.
About the Authors
A. S. Anikeev
Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
6 Miklouho-Maclay Str., Moscow, 117198
N. M. Startseva
Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
6 Miklouho-Maclay Str., Moscow, 117198
V. M. Grabovsky
Municipal Clinical Hospital No. 52 of the Moscow Department of Health
Russian Federation
Russian Federation
3 Pekhotnaya Str., Moscow, 123182
I. M. Ordiyants
Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
6 Miklouho-Maclay Str., Moscow, 117198
L. G. Gazaryan
Peoples’ Friendship University of Russia
Russian Federation
Russian Federation
6 Miklouho-Maclay Str., Moscow, 117198
A. M. Savicheva
Municipal Clinical Hospital No. 29 n.a. N.E. Bauman of the Moscow Department of Health
Russian Federation
Russian Federation
2 Hospital Square, Moscow, 105094
References
1. Ottanelli S., Napoli A., Festa C., Clemenza S. et al. Hypertension and preeclampsia in pregnancy complicated by diabetes. In: Lapolla A., Metzger B.E., eds. Gestational diabetes. A decade after the HAPO Study. Front. Diabetes. Basel: Karger Publishers; 2020. Vol. 28:171–82. DOI: 10.1159/000480173
2. Belay Tolu L., Yigezu E., Urgie T., Feyissa G.T. Maternal and perinatal outcome of preeclampsia without severe feature among pregnant women managed at a tertiary referral hospital in urban Ethiopia. PloS One. 2020;15(4):e0230638. DOI: 10.1371/journal.pone.0230638
3. Karasneh R.A., Migdady F.H., Alzoubi K.H., Al-Azzam S.I. et al. Trends in maternal characteristics, and maternal and neonatal outcomes of women with gestational diabetes: a study from Jordan. Ann. Med. Surg. 2021;67:102469. DOI: 10.1016/j.amsu.2021.102469
4. Murray S.R., Reynolds R.M. Short-and long-term outcomes of gestational diabetes and its treatment on fetal development. Prenat. Diagn. 2020;40(9):1085–91. DOI: 10.1002/pd.5768
5. Lemelin A., Paré G., Bernard S., Godbout A. Demonstrated costeffectiveness of a telehomecare program for gestational diabetes mellitus management. Diabetes Technol. Ther. 2020;22(3):195– 202. DOI: 10.1089/dia.2019.0259
6. Karrar S.A., Hong P.L. Preeclampsia. StatPearls Publishing; 2022. URL: https://www.ncbi.nlm.nih.gov/books/NBK570611 (дата обращения — 13.03.2023).
7. Caropreso L., de Azevedo Cardoso T., Eltayebani M., Frey B.N. Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis. Arch. Womens Mental Health. 2020;23(4):493–505. DOI: 10.1007/s00737-019-01010-1
8. Ashraf U.M., Hall D.L., Rawls A.Z., Alexander B.T. Epigenetic processes during preeclampsia and effects on fetal development and chronic health. Clin. Sci. 2021;135(1):2307–27. DOI: 10.1042/CS20190070
9. All-Russian Diabetological Congress with international participation “Diabetes mellitus — a pandemic of the XXI century”. Bulletin of Endocrinology. 2018;1 (newsletter). (in Russian)
10. Wainstock T., Sergienko R., Sheiner E. Who is at risk for preeclampsia? Risk factors for developing initial preeclampsia in a subsequent pregnancy. J. Clin. Med. 2020;9(4):1103. DOI: 10.3390/jcm9041103
11. Mustafa M., Bogdanet D., Khattak A., Carmody L.A. et al. Early gestational diabetes mellitus (GDM) is associated with worse pregnancy outcomes compared with GDM diagnosed at 24–28 weeks gestation despite early treatment. QJM. 2021;114(1):17–24. DOI: 10.1093/qjmed/hcaa167
12. Boriboonhirunsarn D., Sunsaneevithayakul P., Pannin C., Wamuk T. Prevalence of early-onset GDM and associated risk factors in a university hospital in Thailand. J. Obstet. Gynaecol. 2021;41(6):915–19. DOI: 10.1080/01443615.2020.1820469
13. Kapustin R.V. Pregnancy and diabetes mellitus: pathogenesis, forecasting obstetrical and perinatal complications, gestation and delivery management: abstract of dr. med. theses. St. Petersburg: D.O. Ott Scientific Research Institute of Obstetrics, Gynaecology and Reproductive Medicine; 2021. 46 p. (in Russian)
14. Immanuel J., Eagleton C., Baker J., Simmons D. Pregnancy outcomes among multi-ethnic women with different degrees of hyperglycaemia during pregnancy in an urban New Zealand population and their association with postnatal HbA1c uptake. Aust. N Z J. Obstet. Gynaecol. 2021;61(1):69–77. DOI: 10.1111/ajo.13231
15. Zheng W., Huang W., Liu C., Yan Q. et al. Weight gain after diagnosis of gestational diabetes mellitus and its association with adverse pregnancy outcomes: a cohort study. BMC Pregnancy Childbirth. 2021;21(1):216. DOI: 10.1186/s12884-021-03690-z
16. Shi P., Liu A., Yin X. Association between gestational weight gain in women with gestational diabetes mellitus and adverse pregnancy outcomes: a retrospective cohort study. BMC Pregnancy Childbirth. 2021;21(1):508. DOI: 10.1186/s12884-021-03982-4
17. Lewandowska M., Więckowska B., Sajdak S. Pre-pregnancy obesity, excessive gestational weight gain, and the risk of pregnancy-induced hypertension and gestational diabetes mellitus. J. Clin. Med. 2020;9(6):1980. DOI: 10.3390/jcm9061980
18. Cosson E., Vicaut E., Berkane N., Cianganu T.L. et al. Prognosis associated with initial care of increased fasting glucose in early pregnancy: a retrospective study. Diabetes Metab. 2021;47(3):101197. DOI: 10.1016/j.diabet.2020.08.007
19. Kalok A., Ong M.Y., Hasrori A., Chiang K.S. et al. Correlation between oral glucose tolerance test abnormalities and adverse pregnancy outcomes in gestational diabetes: a cross-sectional study. Int. J. Environ. Res. Public Health. 2020;17(19):6990. DOI: 10.3390/ijerph17196990
20. Mane L., Flores-Le Roux J.A., Pedro-Botet J., Gortazar L. et al. Is fasting plasma glucose in early pregnancy a better predictor of adverse obstetric outcomes than glycated haemoglobin? Eur. J. Obstet. Gynecol. Reprod. Biol. 2019;234:79–84. DOI: 10.1016/j.ejogrb.2018.12.036
21. Kattini R., Hummelen R., Kelly L. Early gestational diabetes mellitus screening with glycated hemoglobin: a systematic review. J. Obstet. Gynaecol. Can. 2020;42(11):1379–84. DOI: 10.1016/j.jogc.2019.12.015
22. Yin B., Hu L., Meng X., Wu K. et al. Association of higher HbA1c within the normal range with adverse pregnancy outcomes: a crosssectional study. Acta Diabetol. 2021;58(8):1081–9. DOI: 10.1007/s00592-021-01691-0
23. Osuagwu U.L., Fuka F., Agho K., Khan A. et al. Adverse maternal outcomes of Fijian women with gestational diabetes mellitus and the associated risk factors. Reprod. Sci. 2020;27(11):2029–37. DOI: 10.1007/s43032-020-00222-6
24. Zehravi M., Maqbool M., Ara I. Correlation between obesity, gestational diabetes mellitus, and pregnancy outcomes: an overview. Int. J. Adolesc. Med. Health. 2021;33(6):339–45. DOI: 10.1515/ijamh-2021-0058
25. Mills G., Badeghiesh A., Suarthana E., Baghlaf H. et al. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum. Reprod. 2020;35(7):1666–74. DOI: 10.1093/humrep/deaa099
26. Manoharan V., Wong V.W. Impact of comorbid polycystic ovarian syndrome and gestational diabetes mellitus on pregnancy outcomes: a retrospective cohort study. BMC Pregnancy Childbirth. 2020;20(1):484. DOI: 10.1186/s12884-020-03175-5
27. Li X., Liu X., Zuo Y., Gao J. et al. The risk factors of gestational diabetes mellitus in patients with polycystic ovary syndrome: what should we care. Medicine (Baltimore). 2021;100(31):e26521. DOI: 10.1097/MD.0000000000026521
28. Rana S., Lemoine E., Granger J.P., Karumanchi S.A. Preeclampsia: pathophysiology, challenges, and perspectives. Circ. Res. 2019;124(7):1094–112. DOI: 10.1161/CIRCRESAHA.118.313276
29. Nuzzo A.M., Giuffrida D., Moretti L., Re P. et al. Placental and maternal sFlt1/PlGF expression in gestational diabetes mellitus. Sci. Rep. 2021;11(1):2312. DOI: 10.1038/s41598-021-81785-5
30. Olmos-Ortiz A., Flores-Espinosa P., Díaz L., Velázquez P. et al. Immunoendocrine dysregulation during gestational diabetes mellitus: the central role of the placenta. Int. J. Mol. Sci. 2021;22(15):8087. DOI: 10.3390/ijms22158087
31. Carrasco-Wong I., Moller A., Giachini F.R., Lima V.V. et al. Placental structure in gestational diabetes mellitus. Biochim. Biophys. Acta Mol. Basis Dis. 2020;1866(2):165535. DOI: 10.1016/j.bbadis.2019.165535
32. Clyne A. M. Endothelial response to glucose: dysfunction, metabolism, and transport. Biochem. Soc. Trans. 2021;49(1):313–25. DOI: 10.1042/BST20200611
33. Martin-Aragon Baudel M., Espinosa-Tanguma R., Nieves-Cintron M., Navedo M.F. Purinergic signaling during hyperglycemia in vascular smooth muscle cells. Front. Endocrinol. 2020;11:329. DOI: 10.3389/fendo.2020.00329
34. Baumüller S., Lehnen H., Schmitz J., Fimmers R. et al. The impact of insulin treatment on the expression of vascular endothelial cadherin and beta-catenin in human fetoplacental vessels. Pediatr. Dev. Pathol. 2015;18(1):17–23. DOI: 10.2350/13-11-1400-OA.1
35. Rao R., Sen S., Han B., Ramadoss S. et al. Gestational diabetes, preeclampsia and cytokine release: similarities and differences in endothelial cell function. Adv. Exp. Med. Biol. 2014;814:69–75. DOI: 10.1007/978-1-4939-1031-1_6
36. Akhmetova E.S., Lareva N.V., Mudrov V.A., Gergesova E.E. Features of pregnancy in gestational diabetes mellitus and prediction of diabetic fetopathy. Journal of Obstetrics and Womens Diseases. 2017;66(4):14–24. (in Russian). DOI: 10.17816/JOWD66414-24
37. Alqudah A., Eastwood K.A., Jerotic D., Todd N. et al. FKBPL and SIRT-1 are downregulated by diabetes in pregnancy impacting on angiogenesis and endothelial function. Front. Endocrinol. 2021;12:650328. DOI: 10.3389/fendo.2021.650328
38. Roberts J.M., Rich-Edwards J.W., McElrath T.F., Garmire L. et al. Subtypes of preeclampsia: recognition and determining clinical usefulness. Hypertension. 2021;77(5):1430–41. DOI: 10.1161/HYPERTENSIONAHA.120.14781
39. Valent A.M., Choi H., Kolahi K.S., Thornburg K.L. Hyperglycemia and gestational diabetes suppress placental glycolysis and mitochondrial function and alter lipid processing. FASEB J. 2021;35(3):e21423. DOI: 10.1096/fj.202000326RR
40. Song T.R., Su G.D., Chi Y.L., Wu T. et al. Dysregulated miRNAs contribute to altered placental glucose metabolism in patients with gestational diabetes via targeting GLUT1 and HK2. Placenta. 2021;105:14–22. DOI: 10.1016/j.placenta.2021.01.015
41. Odenkirk M.T., Stratton K.G., Gritsenko M.A., Bramer L.M. et al. Unveiling molecular signatures of preeclampsia and gestational diabetes mellitus with multi-omics and innovative cheminformatics visualization tools. Mol. Omics. 2020;16(6):521–32. DOI: 10.1039/d0mo00074d
42. Hu M., Li J., Baker P.N., Tong C. et al. Revisiting preeclampsia: a metabolic disorder of the placenta. FEBS J. 2022;289(2):336–54. DOI: 10.1111/febs.15745
43. Hu B., Li D., Tang D., Shangguan Y. et al. Integrated proteome and acetylome analyses unveil protein features of gestational diabetes mellitus and preeclampsia. Proteomics. 2022;22(22):e2200124. DOI: 10.1002/pmic.202200124
44. Startseva N.M., Sviridova M.I., Uchamprina V.A., Anikeev A.S. et al. Heterogeneity of anemic syndrome in obesity and gestational diabetes mellitus. Womens Health and Reproduction: online publication. 2021;2(49). (in Russian). URL: https://journalgynecology.ru/statyi/geterogennostanemicheskogo-sindroma-pri-ozhirenii-i-gestacionnom-saharnomdiabete/ (дата обращения — 24.02.2023)
45.
Review
For citations:
Anikeev A.S., Startseva N.M., Grabovsky V.M., Ordiyants I.M., Gazaryan L.G., Savicheva A.M. Features of Metabolism in Women with Preeclampsia Combined with Gestational Diabetes Mellitus. Title. 2023;22(1):62-67. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-1-62-67
Views:
11
Email this article 